| molecular function |
|---|
| | GO:0019960 | | C-X3-C chemokine binding | | Interacting selectively and non-covalently with a C-X3-C chemokine; C-X3-C chemokines have three amino acids between the first two cysteines of the characteristic four-cysteine motif. |
| | GO:0050839 | | cell adhesion molecule binding | | Interacting selectively and non-covalently with a cell adhesion molecule. |
| | GO:0015026 | | coreceptor activity | | Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity. |
| | GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| | GO:0050840 | | extracellular matrix binding | | Interacting selectively and non-covalently with a component of the extracellular matrix. |
| | GO:0017134 | | fibroblast growth factor binding | | Interacting selectively and non-covalently with a fibroblast growth factor. |
| | GO:0001968 | | fibronectin binding | | Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0031994 | | insulin-like growth factor I binding | | Interacting selectively and non-covalently with insulin-like growth factor I. |
| | GO:0038132 | | neuregulin binding | | Interacting selectively and non-covalently with a neuregulin, a member of the EGF family of growth factors. |
| | GO:0005161 | | platelet-derived growth factor receptor binding | | Interacting selectively and non-covalently with the platelet-derived growth factor receptor. |
| | GO:0002020 | | protease binding | | Interacting selectively and non-covalently with any protease or peptidase. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0003756 | | protein disulfide isomerase activity | | Catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins. |
| | GO:0043184 | | vascular endothelial growth factor receptor 2 binding | | Interacting selectively and non-covalently with vascular endothelial growth factor receptor 2. |
| | GO:0001618 | | virus receptor activity | | Combining with a virus component and mediating entry of the virus into the cell. |
| biological process |
|---|
| | GO:0032147 | | activation of protein kinase activity | | Any process that initiates the activity of an inactive protein kinase. |
| | GO:0060055 | | angiogenesis involved in wound healing | | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury. |
| | GO:0038027 | | apolipoprotein A-I-mediated signaling pathway | | A series of molecular signals initiated by the binding of apolipoprotein A-I to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0007596 | | blood coagulation | | The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers. |
| | GO:0007155 | | cell adhesion | | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
| | GO:0016049 | | cell growth | | The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present. |
| | GO:0016477 | | cell migration | | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
| | GO:0007160 | | cell-matrix adhesion | | The binding of a cell to the extracellular matrix via adhesion molecules. |
| | GO:0031589 | | cell-substrate adhesion | | The attachment of a cell to the underlying substrate via adhesion molecules. |
| | GO:0007044 | | cell-substrate junction assembly | | The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate. |
| | GO:0030198 | | extracellular matrix organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. |
| | GO:0034113 | | heterotypic cell-cell adhesion | | The attachment of a cell to a cell of a different type via adhesion molecules. |
| | GO:0007229 | | integrin-mediated signaling pathway | | A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0050900 | | leukocyte migration | | The movement of a leukocyte within or between different tissues and organs of the body. |
| | GO:0048333 | | mesodermal cell differentiation | | The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell. |
| | GO:0050919 | | negative chemotaxis | | The directed movement of a motile cell or organism towards a lower concentration of a chemical. |
| | GO:0010888 | | negative regulation of lipid storage | | Any process that decreases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. |
| | GO:0032369 | | negative regulation of lipid transport | | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0050748 | | negative regulation of lipoprotein metabolic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids. |
| | GO:0045715 | | negative regulation of low-density lipoprotein particle receptor biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of low-density lipoprotein particle receptors. |
| | GO:0010745 | | negative regulation of macrophage derived foam cell differentiation | | Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. |
| | GO:0030168 | | platelet activation | | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
| | GO:0070527 | | platelet aggregation | | The adhesion of one platelet to one or more other platelets via adhesion molecules. |
| | GO:0002576 | | platelet degranulation | | The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
| | GO:0010595 | | positive regulation of endothelial cell migration | | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
| | GO:0001938 | | positive regulation of endothelial cell proliferation | | Any process that activates or increases the rate or extent of endothelial cell proliferation. |
| | GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| | GO:0030949 | | positive regulation of vascular endothelial growth factor receptor signaling pathway | | Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity. |
| | GO:0045124 | | regulation of bone resorption | | Any process that modulates the frequency, rate or extent of bone tissue loss (resorption). |
| | GO:0030334 | | regulation of cell migration | | Any process that modulates the frequency, rate or extent of cell migration. |
| | GO:0014909 | | smooth muscle cell migration | | The orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism. |
| | GO:0034446 | | substrate adhesion-dependent cell spreading | | The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate. |
| | GO:0035295 | | tube development | | The process whose specific outcome is the progression of a tube over time, from its initial formation to a mature structure. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues including lung and trachea, kidney, the mammary gland, the vascular system and the gastrointestinal and urinary-genital tracts. |
| | GO:0048010 | | vascular endothelial growth factor receptor signaling pathway | | Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0046718 | | viral entry into host cell | | The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm. |
| | GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
| | GO:0042060 | | wound healing | | The series of events that restore integrity to a damaged tissue, following an injury. |
| cellular component |
|---|
| | GO:0035867 | | alphav-beta3 integrin-IGF-1-IGF1R complex | | A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits. |
| | GO:0071062 | | alphav-beta3 integrin-vitronectin complex | | A protein complex that consists of an alphav-beta3 integrin complex bound to vitronectin. |
| | GO:0030054 | | cell junction | | A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix. |
| | GO:0042995 | | cell projection | | A prolongation or process extending from a cell, e.g. a flagellum or axon. |
| | GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0031527 | | filopodium membrane | | The portion of the plasma membrane surrounding a filopodium. |
| | GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005887 | | integral component of plasma membrane | | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0034683 | | integrin alphav-beta3 complex | | An integrin complex that comprises one alphav subunit and one beta3 subunit. |
| | GO:0008305 | | integrin complex | | A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands. |
| | GO:0031258 | | lamellipodium membrane | | The portion of the plasma membrane surrounding a lamellipodium. |
| | GO:0042470 | | melanosome | | A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0031528 | | microvillus membrane | | The portion of the plasma membrane surrounding a microvillus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0031092 | | platelet alpha granule membrane | | The lipid bilayer surrounding the platelet alpha granule. |
| | GO:0043235 | | receptor complex | | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| | GO:0032587 | | ruffle membrane | | The portion of the plasma membrane surrounding a ruffle. |
Description
